Answers are grounded in this paper and cite their sources.
Objectives Point of care lung ultrasound enables instant structure evaluation, identifying pneumonia markers like consolidation, pleural effusion, and lung artifacts. This strategy reduces reliance on conventional imaging, curtails radiation exposure, and provides prompt bedside outcomes, particularly advantageous for acutely unwell Paediatric cases. The primary aim of this study is to delineate the lung ultrasound findings that are correlated with Ventilator-Associated Pneumonia (VAP). Additionally, the study seeks to evaluate the diagnostic precision of lung ultrasound in contrast to clinical, microbiological, and radiological criteria. In minimum words Methods This prospective observational study was carried out within the Pediatric Intensive Care Unit (PICU) of the Department of Pediatrics at King George's Medical University. The study was designed based on prior prevalence data(Awasthi S et al 2013) Results Lung ultrasound characteristics: Multiple B lines – 62% Subpleural consolidation – 19% Pleural effusion – 12% Shred sign + Air bronchogram – 7% VAP Incidence Density- VAP Rate per 1,000 ventilator days 84/252*1000 =333.3(over 10 months) Time of Appearance- In the study, the onset of VAP was observed at different times with various diagnostic methods. Lung ultrasound (LUS) showed the earliest appearance of VAP at 3.1 ± 0.81 days, followed by CXR (Chest X-ray) at 4.22 ± 1.23 days, followed by microbiological culture at 4.5 ± 1.3 days. Which was statistically significant (p<0.0001). When LUS was used in the Clinical Pulmonary Infection Score instead of CXR, the diagnostic accuracy remained similar (p>0.05). In the early days (3 and 4 days), LUS showed better diagnostic accuracy with an AUC (Area Under the Curve) of 0.70–0.74 and sensitivity ranging from 57% to 90%, while CXR had an AUC of 0.5 and sensitivity ranging from 16.7% to 83%. However, from the fifth day onwards, CXR demonstrated better AUC (0.79–0.81) compared to LUS (0.54–0.70). Summary-The study found that LUS and CXR had different timing for detecting VAP, with LUS showing earlier detection, especially in the early days, while CXR became more accurate from the fifth day onwards. Other individual parameters did not significantly differ between the VAP and non-VAP groups. Conclusion This study highlights the prowess of lung ultrasound as a promising diagnostic instrument, characterized by heightened sensitivity, expedited results, and an absence of radiation exposure in lesser time.
No takes yet. Share an insight, caveat, or question.
Yadav et al. (2024) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: